Indicative Announcement on Equity Change by Controlling Shareholder and Persons Acting in Concert
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Indicative Announcement on Equity Change by Controlling Shareholder and Persons Acting in Concert
Filed with SSE · · 3 pages · Chinese
Release
Beijing Sun-Novo Pharmaceutical Research Co. Ltd. on 6ix
Earlier from Beijing Sun-Novo Pharmaceutical Research
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
- 2025 Semi-annual Report
- Announcement on Cancellation of Some Special Accounts for Raised Funds
- Announcement on Progress in Trading for Planning to Issue Shares and Convertible Corporate Bonds to Purchase Assets and Raise Supporting Funds as well as Related Party Transactions
Later from Beijing Sun-Novo Pharmaceutical Research
- Voluntary Announcement on Extension of Affiliated Company's Plan to Purchase the Company's Shares
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Clinical Trials of BTP4507
- Announcement on Convening Investor Briefing on Major Asset Restructuring Matters
- Announcement on Postponing the 4th Extraordinary General Meeting in 2025
- Announcement on Postponing the 4th Extraordinary General Meeting in 2025 for Another Time
Follow Beijing Sun-Novo Pharmaceutical Research into a list and get an email when it puts out news.
Follow Beijing Sun-Novo Pharmaceutical Research